Imunon (IMNN) Total Non-Current Liabilities (2010 - 2022)

Imunon (IMNN) has 13 years of Total Non-Current Liabilities data on file, last reported at $13.8 million in Q3 2022.

• Quarterly Total Non-Current Liabilities rose 7.84% year-over-year to $13.8 million in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $13.8 million (up 7.84% YoY) and the FY2021 annual result came in at $12.9 million, up 8.04% from the prior year.
• Total Non-Current Liabilities advanced to $13.8 million in Q3 2022, from $12.9 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $30.3 million in Q2 2018 to a low of $10.9 million in Q1 2021.
• A 5-year average of $16.9 million and a median of $16.5 million in 2020 frame the typical range for Total Non-Current Liabilities.
• Annual changes were most pronounced in 2018 — Total Non-Current Liabilities jumped 229.01% — and 2020, when it tumbled 40.36%.
• Tracing IMNN's Total Non-Current Liabilities over 5 years: stood at $25.9 million in 2018, then tumbled by 30.58% to $18.0 million in 2019, then plunged by 33.9% to $11.9 million in 2020, then increased by 8.04% to $12.9 million in 2021, then advanced by 7.23% to $13.8 million in 2022.
• The last three Total Non-Current Liabilities figures came in at $13.8 million (Q3 2022), $12.9 million (Q2 2022), and $12.7 million (Q1 2022), per Business Quant data.